$VATE

INNOVATE Corp.

No enriched coverage for $VATE in the last 7 days.

No SEC Form 4 filings for $VATE in the last 30 days.

Low

Executive pay, equity plan and auditor on ballot at INNOVATE Corp (VATE) 2026 meeting

INNOVATE Corp (VATE) will hold its 2026 annual shareholder meeting virtually on June 11, 2026, where stockholders will vote on electing four directors, an advisory vote on executive compensation, an increase in shares for the Omnibus Equity Award Plan, and ratifying BDO USA, P.C. as auditor. The board recommends voting "FOR" all proposals. The company also reported 2025 business highlights, including significant revenue growth for DBM Global and key product approvals for MediBeacon.

Reitar Logtech and INNOVATE: Comparing Conglomerates

This article compares two small-cap conglomerate companies, INNOVATE (NYSE:VATE) and Reitar Logtech (NASDAQ:RITR), which operate in diverse sectors. It examines their business models, risk profiles, and financial metrics to help investors determine which might be a better investment. INNOVATE focuses on infrastructure, life sciences, and spectrum, while Reitar Logtech specializes in construction management, engineering design, and asset management services.

INNOVATE Corp Reports Strong Q4 2025 Revenue Growth

INNOVATE Corp (VATE) announced strong revenue growth for Q4 2025 and the full year, driven primarily by its Infrastructure segment. The company also secured FDA approval for its Life Sciences product and saw regulatory tailwinds in its Spectrum segment, despite some quarterly softness. However, TipRanks' AI Analyst Spark rates VATE as Neutral due to weak financial quality despite revenue growth.

News on $VATE